Nonalcoholic Steatohepatitis Is Associated With Increased Mortality in Obese Patients Undergoing Bariatric Surgery
Open accessThe DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Abstract
Background & Aims Bariatric surgery is associated with improved outcomes in subjects with severe obesity. We investigated the prognostic relevance of non-alcoholic steatohepatitis (NASH) and liver gene expression patterns in patients undergoing bariatric surgery. Methods We performed a retrospective analysis of 492 subjects who underwent gastric bypass bariatric surgery at a single center in Switzerland from January 1997 through December 2004; routine peri-operative liver biopsies were collected, analyzed histologically, and RNA was isolated. We collected data on overall survival and clinical and biochemical parameters and compared these with data from propensity score-matched subjects participating in the third National Health and Nutrition Examination Survey (NHANES III). We used liver biopsies to identify bariatric surgery patients with NASH; NHANES III participants with NASH were identified based on a hyperechogenic liver at ultrasound and increased alanine transaminase levels. We analyzed a 32-gene signature associated with NAFLD severity in the liver tissues collected from 47 bariatric surgery patients with NASH, and assessed its prognostic features using nearest template prediction and survival analysis. Results At baseline, the median body mass index of patients who underwent bariatric surgery was 43.6 kg/m2; based on histologic findings, 12% had NASH and 16% had fibrosis. During a median follow-up of 10.2 years after the surgery, 4.2% of the subjects died. In multivariable Cox regression, the presence of NASH (hazard ratio [HR], 2.9; P=.02) and arterial hypertension (HR, 3.9; P=.02) were associated with overall mortality. When bariatric surgery patients were matched with NHANES III participants, bariatric surgery reduced the risk of death during the follow-up period (HR, 0.54; P=.04). However, bariatric surgery patients with NASH did not have a reduced risk of death compared to NHANES III participants with NASH (HR, 0.90; P=.85). We identified an expression pattern of 32 genes in liver tissues from patients with NASH that was associated with increased risk of death in multivariable analysis (HR, 7.7; P=.045). Conclusions Histologically proven NASH is associated with increased risk of death within a median follow-up of 10.2 years after bariatric surgery, compared to patients who undergo bariatric surgery without NASH. The survival benefit of bariatric surgery in subjects with NASH may be reduced. A 32-gene expression pattern identified NASH patients who underwent bariatric surgery and had shorter survival times.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Effects of Bariatric Surgery on Mortality in Swedish Obese Subjects
Sjöström, L., Narbro, K., Sjöström, C. D., Karason, K., Larsson, B., Wedel, H., Lystig, T., Sullivan, M., Bouchard, C., Carlsson, B., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa066254 · Cited by 4,668
Long-term mortality after gastric bypass surgery
Adams, T. D., Gress, R. E., Smith, S. C., Halverson, R. C., Simper, S. C., Rosamond, W. D., LaMonte, M. J., Stroup, A. M., & Hunt, S. C. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa066603 · Cited by 2,572
Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity
Henao-Mejia, J., Elinav, E., Jin, C., Hao, L., Mehal, W. Z., Strowig, T., Thaiss, C. A., Kau, A. L., Eisenbarth, S. C., Jurczak, M. J., et al. (2012) · Nature · doi:10.1038/nature10809 · Cited by 2,435
Ekstedt, M., Hagström, H., Nasr, P., Fredrikson, M., Stål, P., Kechagias, S., & Hultcrantz, R. (2015) · Hepatology · doi:10.1002/hep.27368 · Cited by 2,287 · cited 2×
“Total, n 21 (4) 471 (96) Clinical Male sex 9 (43) 80 (17) Age (>50 y) 12 (57) 92 (19) BMI (>45 kg/m(2)) 11 (52) 170 (36) Diabetes 8 (38) 74 (16) Arterial hypertension 16 (76) 139 (30) OSA 4 (19) 63 (13) Ever smoked 9 (45) 127 (46) Histology NAFLD (steatosis >5%) 20 (95) 419 (89) NASH 8 (38) 51 (11) Fibrosis 8 (38) 69…”
Perioperative safety in the longitudinal assessment of bariatric surgery
(2009) · New England Journal of Medicine · doi:10.1056/nejmoa0901836 · Cited by 1,392 · cited 1×
“Total, n 21 (4) 471 (96) Clinical Male sex 9 (43) 80 (17) Age (>50 y) 12 (57) 92 (19) BMI (>45 kg/m(2)) 11 (52) 170 (36) Diabetes 8 (38) 74 (16) Arterial hypertension 16 (76) 139 (30) OSA 4 (19) 63 (13) Ever smoked 9 (45) 127 (46) Histology NAFLD (steatosis >5%) 20 (95) 419 (89) NASH 8 (38) 51 (11) Fibrosis 8 (38) 69…”
Brunt, E. M., Kleiner, D. E., Wilson, L. A., Belt, P., & Neuschwander-Tetri, B. A. (2011) · Hepatology · doi:10.1002/hep.24127 · Cited by 1,251
Long-term Follow-up After Bariatric Surgery: A Systematic Review
Puzziferri, N., Roshek, T. B., Mayo, H. G., Gallagher, R., Belle, S. H., & Livingston, E. H. (2014) · JAMA · doi:10.1001/jama.2014.10706 · Cited by 819
Cited by
Estes, C., Razavi, H., Loomba, R., Younossi, Z., & Sanyal, A. J. (2018) · Hepatology · doi:10.1002/hep.29466 · Cited by 2,399
Dulai, P. S., Singh, S., Patel, J., Soni, M., Prokop, L. J., Younossi, Z., Sebastiani, G., Ekstedt, M., Hagstrom, H., Nasr, P., et al. (2017) · Hepatology · doi:10.1002/hep.29085 · Cited by 1,965
“We have provided estimates for mortality rates which are of significance when engaging in the shared decision-making process with patients and when designing therapeutic intervention trials aimed at preventing fibrosis progression to prevent disease-related complications and offset the natural course of NAFLD.”
BackgroundInfluentialObesity and nonalcoholic fatty liver disease: From pathophysiology to therapeutics
Polyzos, S. A., Kountouras, J., & Mantzoros, C. S. (2019) · Metabolism · doi:10.1016/j.metabol.2018.11.014 · Cited by 1,211
Pouwels, S., Sakran, N., Graham, Y., Leal, A., Pintar, T., Yang, W., Kassir, R., Singhal, R., Mahawar, K., & Ramnarain, D. (2022) · BMC Endocrine Disorders · doi:10.1186/s12902-022-00980-1 · Cited by 897
Stefan, N., Häring, H.-U., & Cusi, K. (2019) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(18)30154-2 · Cited by 837
Metadata
- Authors
- Goossens, N., Hoshida, Y., Song, W. M., Jung, M., Morel, P., Nakagawa, S., Zhang, B., Frossard, J.-L., Spahr, L., Friedman, S. L., Negro, F., Rubbia-Brandt, L., & Giostra, E.
- Venue
- Clinical Gastroenterology and Hepatology
- Publisher
- Elsevier BV
- Published
- 2016-11
- Volume
- 14
- Issue
- 11
- Pages
- 1619-1628
- ISSN
- 1542-3565 (ISSN-L)
- OpenAlex
- W2103703914
- Cited by
- 61
- References
- 7
- FWCI
- 6.36
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Nonalcoholic Steatohepatitis Is Associated With Increased Mortality in Obese Patients Undergoing Bariatric Surgery. https://app.cochat.ai/papers/10.1016/j.cgh.2015.10.010
- The paper
- Goossens, N., Hoshida, Y., Song, W. M., Jung, M., Morel, P., Nakagawa, S., Zhang, B., Frossard, J.-L., Spahr, L., Friedman, S. L., Negro, F., Rubbia-Brandt, L., & Giostra, E. (2016). Nonalcoholic Steatohepatitis Is Associated With Increased Mortality in Obese Patients Undergoing Bariatric Surgery. Clinical Gastroenterology and Hepatology. https://doi.org/10.1016/j.cgh.2015.10.010
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.